Harmony Biosciences Holdings, Inc. (HRMY)
40.30
+0.70
(+1.77%)
USD |
NASDAQ |
Oct 09, 16:00
40.30
0.00 (0.00%)
After-Hours: 17:57
Harmony Biosciences Holdings Cash from Operations (Quarterly) : 92.43M for June 30, 2026
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 92.43M |
| March 31, 2026 | 27.76M |
| December 31, 2025 | 126.15M |
| September 30, 2025 | 108.73M |
| June 30, 2025 | 79.33M |
| March 31, 2025 | 33.99M |
| December 31, 2024 | 75.56M |
| September 30, 2024 | 70.50M |
| June 30, 2024 | 42.62M |
| March 31, 2024 | 31.14M |
| December 31, 2023 | 76.66M |
| September 30, 2023 | 63.10M |
| June 30, 2023 | 37.06M |
| March 31, 2023 | 42.56M |
| December 31, 2022 | 26.68M |
| Date | Value |
|---|---|
| September 30, 2022 | 55.20M |
| June 30, 2022 | 33.73M |
| March 31, 2022 | 28.85M |
| December 31, 2021 | 37.53M |
| September 30, 2021 | 30.42M |
| June 30, 2021 | 18.07M |
| March 31, 2021 | 12.53M |
| December 31, 2020 | 10.05M |
| September 30, 2020 | 8.838M |
| June 30, 2020 | 4.832M |
| March 31, 2020 | -26.70M |
| December 31, 2019 | -23.99M |
| September 30, 2019 | -23.45M |
| June 30, 2019 | -17.40M |
| March 31, 2019 | -10.60M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Liquidia Corp. | 80.24M |
| Pfizer Inc. | 835.00M |
| Bristol Myers Squibb Co. | 3.393B |
| Repligen Corp. | 32.77M |
| Johnson & Johnson | 8.616B |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -131.50M |
| Cash from Financing (Quarterly) | -0.558M |
| Free Cash Flow | 335.65M |
| Free Cash Flow Per Share (Quarterly) | 1.573 |
| Free Cash Flow to Equity (Quarterly) | 77.98M |
| Free Cash Flow to Firm (Quarterly) | 94.92M |
| Free Cash Flow Yield | 14.18% |